Literature DB >> 25801418

The Cholera Toxin B Subunit (CTB) Fused to the Porcine Arterivirus Matrix M and GP5 Envelope Proteins Fails to Enhance the GP5-Specific Antibody Response in Pigs Immunized with Adenovectors.

Elodie Roques1, Martin Lessard, Denis Archambault.   

Abstract

The porcine reproductive and respiratory syndrome virus (PRRSV) is an arterivirus of the Arteriviridae family. As the current commercial vaccines are incompletely protective effective against PRRSV infection, we developed a vaccine strategy using replicating but non-disseminating adenovectors (rAdVs) expressing the PRRSV M matrix protein in fusion with the neutralizing major epitope-carrying GP5 envelope protein (Roques et al. in Vet Res 44:17, 2013). Although production of GP5-specific antibodies (Abs) was observed, no PRRSV-specific neutralizing Abs (NAbs) were induced in pigs given the rAdVs expressing M-GP5 or M-GP5m (GP5m being a mutant form of GP5). Nevertheless, partial protection was observed in the M-GP5m-rAdV-inoculated pigs experimentally infected with PRRSV. Here, we determined the impact of the cholera toxin B subunit (CTB, known for its adjuvant effect) in fusion with the C-terminus of M-GP5m on the Ab response to PRRSV. Three-week-old pigs were immunized twice both intramuscularly and intranasally at 3-week intervals with rAdV-expressing the green fluorescent protein (rAdV-GFP), rAdV-M-GP5m, or rAdV-M-GP5m-CTB. Pigs immunized with rAdV-M-GP5m showed a high level of serum GP5-specific Abs (as determined by an indirect ELISA). In contrast, CTB in fusion with M-GP5m had an unexpected severe negative impact on GP5-specific Ab production. PRRSV-specific NAbs could not be detected in any pigs of all groups.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25801418     DOI: 10.1007/s12033-015-9861-6

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  36 in total

1.  Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.

Authors:  F C Pimenta; E N Miyaji; A P M Arêas; M L S Oliveira; A L S S de Andrade; P L Ho; S K Hollingshead; L C C Leite
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

Review 2.  Flagellin as an adjuvant: cellular mechanisms and potential.

Authors:  Steven B Mizel; John T Bates
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

Review 3.  Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS).

Authors:  Michael P Murtaugh; Marika Genzow
Journal:  Vaccine       Date:  2011-09-17       Impact factor: 3.641

4.  Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain.

Authors:  M Ostrowski; J A Galeota; A M Jar; K B Platt; F A Osorio; O J Lopez
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 5.  Cholera toxin - a foe & a friend.

Authors:  Joaquin Sanchez; Jan Holmgren
Journal:  Indian J Med Res       Date:  2011-02       Impact factor: 2.375

6.  Antibody responses induced in mice immunized with recombinant adenovectors expressing chimeric proteins of various porcine pathogens.

Authors:  Elodie Roques; Aurélie Girard; Carl A Gagnon; Denis Archambault
Journal:  Vaccine       Date:  2013-04-10       Impact factor: 3.641

7.  A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

Authors:  Nobuyuki Matoba; Aude Magérus; Brian C Geyer; Yunfang Zhang; Mrinalini Muralidharan; Annette Alfsen; Charles J Arntzen; Morgane Bomsel; Tsafrir S Mor
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-03       Impact factor: 11.205

8.  Fusion-expressed CTB improves both systemic and mucosal T-cell responses elicited by an intranasal DNA priming/intramuscular recombinant vaccinia boosting regimen.

Authors:  Sugan Qiu; Xiaonan Ren; Yinyin Ben; Yanqin Ren; Jing Wang; Xiaoyan Zhang; Yanmin Wan; Jianqing Xu
Journal:  J Immunol Res       Date:  2014-04-01       Impact factor: 4.818

9.  Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  Qisheng Zheng; Desheng Chen; Peng Li; Zhixiang Bi; Ruibing Cao; Bin Zhou; Puyan Chen
Journal:  Virus Genes       Date:  2007-10-06       Impact factor: 2.332

10.  Adenoviral-expressed GP5 of porcine respiratory and reproductive syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions.

Authors:  C A Gagnon; G Lachapelle; Y Langelier; B Massie; S Dea
Journal:  Arch Virol       Date:  2003-05       Impact factor: 2.574

View more
  1 in total

1.  Combined Subcutaneous-Intranasal Immunization With Epitope-Based Antigens Elicits Binding and Neutralizing Antibody Responses in Serum and Mucosae Against PRRSV-2 and SARS-CoV-2.

Authors:  Mario Fragoso-Saavedra; Carmen Ramírez-Estudillo; Diana L Peláez-González; Jorge O Ramos-Flores; Gustavo Torres-Franco; Leandro Núñez-Muñoz; Gabriel Marcelino-Pérez; María G Segura-Covarrubias; Rogelio González-González; Roberto Ruiz-Medrano; Beatriz Xoconostle-Cázares; Amanda Gayosso-Vázquez; Silvia Reyes-Maya; Vianey Ramírez-Andoney; Rogelio A Alonso-Morales; Marco A Vega-López
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.